A First-in-human Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women
NCT00902356
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
69
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteopenia
Interventions
DRUG:
AMG 167
DRUG:
Placebo
Sponsor
Amgen